Newest Vital Sign as a proxy for medication adherence in older adults.
J Am Pharm Assoc (2003)
; 53(6): 611-7, 2013.
Article
em En
| MEDLINE
| ID: mdl-24091561
ABSTRACT
OBJECTIVE:
To assess the utility of the Newest Vital Sign (NVS) as a proxy for medication adherence in community-dwelling older adults.DESIGN:
Descriptive cross-sectional study.SETTING:
12 adult day care centers in the Lisbon metropolitan area, Portugal, between March and May 2009.PARTICIPANTS:
100 white community-dwelling older adults. INTERVENTION Participants were administered the NVS, Single Item Literacy Screener (SILS), and self-reported Measure of Adherence to Therapy (MAT). MAIN OUTCOMEMEASURES:
Health literacy and medication adherence.RESULTS:
The mean (±SD) age of the respondents was 73.3 ± 7.8 years and 71% were women. The NVS score was 0.81 ± 0.10 (of 6 possible points), and 95% of the respondents scored in the three lowest possible scores, indicating a notable floor effect. Age was found to be inversely correlated with NVS score (P = 0.003). The MAT score was 36.2 ± 4.7 (range 17-42). No statistically significant association between the NVS and level of education (P = 0.059 [Kruskal-Wallis]), gender (P = 0.700 [Mann-Whitney]), SILS (P = 0.167), or MAT (P = 0.379) was identified.CONCLUSION:
The utility of the NVS as a proxy for medication adherence in community-dwelling older adults is limited because of a floor effect that hinders its predictive power for medication adherence.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inquéritos e Questionários
/
Avaliação de Resultados em Cuidados de Saúde
/
Adesão à Medicação
/
Letramento em Saúde
Tipo de estudo:
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article